John W. Bristol & Co’s Boston Scientific BSX Stock Holding History

John W. Bristol & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,000	Closed	-$340K	–	85
2021 Q4	$340K	Hold	8,000	–	–	0.01%	84
2021 Q3	$347K	Hold	8,000	–	–	0.01%	83
2021 Q2	$342K	Hold	8,000	–	–	0.01%	84
2021 Q1	$309K	Hold	8,000	–	–	0.01%	83
2020 Q4	$288K	Hold	8,000	–	–	0.01%	74
2020 Q3	$306K	Buy	+8,000	New	+$308K	0.01%	71

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

John W. Bristol & Co's BSX Position: Q1 2022 in Review

John W. Bristol & Co sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 8,000 shares — an estimated $340K sold.

John W. Bristol & Co first reported a position in BSX in Q3 2020 and held it in 6 quarters. The position peaked at $347K in Q3 2021. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

John W. Bristol & Co reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
John W. Bristol & Co sold 8,000 Boston Scientific shares in Q1 2022, an estimated $340K.
John W. Bristol & Co first reported a position in Boston Scientific in Q3 2020 and held it in 6 quarters.
John W. Bristol & Co's Boston Scientific position peaked at $347K in Q3 2021.
904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on John W. Bristol & Co's 13F filing for Q1 2022, filed 10 May 2022.